Cargando…
Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells
Fatty acid synthase (FASN), the key enzyme for endogenous synthesis of fatty acids, is overexpressed and hyperactivated in a biologically aggressive subset of sex steroid-related tumors, including breast carcinomas. Using pharmacological and genetic approaches, we assessed the molecular relationship...
Autores principales: | Menendez, J A, Lupu, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337623/ https://www.ncbi.nlm.nih.gov/pubmed/28240737 http://dx.doi.org/10.1038/oncsis.2017.4 |
Ejemplares similares
-
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer
por: Menendez, Javier A., et al.
Publicado: (2020) -
Schisandrol A Exhibits Estrogenic Activity via Estrogen Receptor α-Dependent Signaling Pathway in Estrogen Receptor-Positive Breast Cancer Cells
por: Lee, Dahae, et al.
Publicado: (2021) -
Differential in radiosensitizing potency of enantiomers of the fatty acid synthase inhibitor C75
por: Rae, Colin, et al.
Publicado: (2016) -
Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer
por: Menendez, Javier A., et al.
Publicado: (2021) -
The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells
por: Menendez, Javier A., et al.
Publicado: (2016)